This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71964963
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im November 1995 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в листопаді 1995 artículu científicu espublizáu en payares de 1995 scientific article published on 01 November 1995
p:P577
wds:Q71964963-5AAE9B01-31C7-4162-89C5-BE12C5585083
wdt:P577
1995-11-01T00:00:00Z
p:P2093
wds:Q71964963-D99427E9-0074-4E3A-A652-F2A4A1A4016C wds:Q71964963-A3CFBC18-C59B-41C8-8FAB-6AE375C9E5AF wds:Q71964963-F6151F83-6A62-4FC2-812E-6677ED3E439D wds:Q71964963-1709FEA2-6105-47FE-85D9-71A693CEA41D wds:Q71964963-3D67590B-3259-472D-B119-5F281012DCFC wds:Q71964963-7AF026BD-D419-44D5-AF4D-B62A9A81220A wds:Q71964963-84695E44-A74E-497F-B68D-581A6493A987
wdt:P2093
G C Pixton E L So L E Gustavson G D Cascino D Wolff N M Graves I E Leppik
rdfs:label
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs
skos:prefLabel
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs
schema:name
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs
p:P1476
wds:Q71964963-719881EC-D9DC-487D-9D3E-C6B1FBA0A86F
wdt:P1476
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs
p:P304
wds:Q71964963-226DA754-7559-42C0-9B4F-A0911ACA1353
wdt:P304
221-226
p:P31
wds:Q71964963-B078D1B6-868C-4615-9B50-286FF5F069A7
wdt:P31
wd:Q13442814
p:P921
wds:Q71964963-24D5B698-B6DC-4DFE-A51C-BF1BB193135E
wdt:P921
wd:Q323936
p:P698
wds:Q71964963-9D94491F-CEB9-41AA-B267-D17D7C40D288
wdtn:P698
n12:8991789
wdt:P698
8991789
p:P1433
wds:Q71964963-5A82E708-BBE2-4EA3-BA60-C50A26282EBC
wdt:P1433
wd:Q15746405
p:P433
wds:Q71964963-6F1694A5-D2BF-4DC1-8971-38F0236C73E1
p:P478
wds:Q71964963-32B54297-4AB1-4D65-B5C9-4F159A64F9E3
wdt:P433
3
wdt:P478
22
p:P356
wds:Q71964963-52221CE0-9576-4AEB-A25E-5417220D3403
wdtn:P356
n9:0920-1211(95)00048-8
wdt:P356
10.1016/0920-1211(95)00048-8